XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.2
CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenues [Abstract]        
Net revenues $ 126,373 $ 115,098 $ 242,604 $ 223,440
Operating costs:        
Salaries and related costs 70,669 64,607 136,936 126,886
Rent, supplies, contract labor and other 23,026 22,168 45,070 43,944
Provision for doubtful accounts 1,240 1,151 2,446 2,212
Closure costs 13 18 9 30
Total operating costs 94,948 87,944 184,461 173,072
Gross Profit 31,425 27,154 58,143 50,368
Corporate office costs 11,527 10,128 22,820 20,291
Operating income 19,898 17,026 35,323 30,077
Other income and expense        
Gain on sale of partnership interest 5,823 0 5,823 0
Interest and other income, net 4 22 20 54
Interest expense (607) (545) (965) (1,098)
Income before taxes 25,118 16,503 40,201 29,033
Provision for income taxes 5,318 3,267 8,026 5,743
Net income 19,800 13,236 32,175 23,290
Less: net income attributable to non-controlling interests:        
Non-controlling interests - permanent equity (1,802) (1,380) (3,339) (2,581)
Redeemable non-controlling interests - temporary equity (3,378) (2,610) (5,773) (4,346)
Less: net income attributable to non-controlling interests (5,180) (3,990) (9,112) (6,927)
Net income attributable to USPH shareholders $ 14,620 $ 9,246 $ 23,063 $ 16,363
Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share) $ 0.85 $ 0.48 $ 1.24 $ 0.74
Shares used in computation - basic and diluted (in shares) 12,767 12,677 12,738 12,647
Dividends declared per common share (in dollars per share) $ 0.27 $ 0.23 $ 0.54 $ 0.46
Net Patient Revenues [Member]        
Revenues [Abstract]        
Net revenues $ 113,363 $ 105,989 $ 220,013 $ 206,541
Other Revenues [Member]        
Revenues [Abstract]        
Net revenues $ 13,010 $ 9,109 $ 22,591 $ 16,899